Thomas Malley
Director at BeOne Medicines AG; Director at Kiniksa Pharmaceuticals International; Director at Kura Oncology.
- Rank
- 9305th of 14,644
- Companies held
- 2
- Largest holding
- KNSA, 88.1% of total
- Latest SEC filing
- May 29, 2026
- Listed but not counted
- $18.7M
What the $9.3M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Kiniksa Pharmaceuticals International KNSA Class A Ordinary Shares | Through Mossrock Capital, LLC | 71,967 | $93.54 | $6.7M | 72.6% | Form 4, May 29, 2026 |
| Kiniksa Pharmaceuticals International KNSA Class A Ordinary Shares | Directly | 15,345 | $93.54 | $1.4M | 15.5% | Form 4, May 29, 2026 |
| Kura Oncology KURA Common Stock | Through Mossrock Capital, LLC | 139,557 | $7.35 | $1.0M | 11.1% | Form 4, Mar 18, 2026 |
| Kura Oncology KURA Common Stock | Directly | 10,000 | $7.35 | $74K | 0.8% | Form 4, Mar 18, 2026 |
Share counts are the amounts Thomas Malley reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Thomas Malley's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| BeOne Medicines AG ONC Ordinary Shares | Directly Not valued: reported in home-market shares, which trade in the US as depositary shares at a different ratio | 46,696 | $399.70 | $18.7M | — | Form 4, Jun 15, 2023 |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 9302 | John J. Abularrage Co-Chief Executive Officer, BGC Group. New York, NY | $9.3M |
| 9303 | H. Sanford Riley Director, CPI Card Group. Littleton, CO | $9.3M |
| 9304 | Kurt Adzema EVP & CFO, Sanmina. San Jose, CA | $9.3M |
| 9305 | Thomas Malley Director, BeOne Medicines AG | $9.3M |
| 9306 | Steve Provost EVP & President Maggiano's, Brinker International. Dallas, TX | $9.3M |
| 9307 | Robert W. Dean II Chief Accounting Officer, Monolithic Power Systems. West Palm Beach, FL | $9.3M |
| 9308 | Anne McCallion Director, PennyMac Financial Services. Westlake Village, CA | $9.3M |
Questions
How much stock does Thomas Malley own?
Thomas Malley holds $9,265,972 in listed stock based on SEC filings and current prices, mostly Kiniksa Pharmaceuticals International (KNSA). That ranks 9305th on the Stock Rich List.
Is this Thomas Malley's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.